论文部分内容阅读
分析河南省1996年结核病耐药监测资料,探讨结核病耐药监测实施方法。结果显示:标本损失量达38.7%,其中由于有CPB(溴化十六烷基铵基吡啶)结晶造成培养不生长而引起的损失量占总损失量的36.8%;用药史不准确致复核后原无用药史者样本量减少12.1%,且费用增加5万元。提示结核病耐药监测中要有效控制标本损失量、准确用药史。
Analyze the data of tuberculosis drug resistance monitoring in 1996 in Henan Province and discuss the implementation of tuberculosis drug resistance monitoring. The results showed that the loss of the specimen reached 38.7%, of which 36.8% of the total loss was due to the lack of growth due to the crystallization of CPB (cetyl ammonium bromide bromide) The original non-medication history sample decreased 12.1%, and the cost increased 50,000 yuan. Tip tuberculosis drug resistance monitoring should effectively control the loss of specimens, accurate medication history.